InhaleRx

NX1 shares surge 35% as Nexalis Therapeutics sets out 2026 clinical roadmap

Finance

NX1 shares surge 35% as Nexalis Therapeutics sets out 2026 clinical roadmap

February 17, 2026

Company Roundup: Avecho, InhaleRx, Neurotech, Peak, Zelira, Argent

Finance

Company Roundup: Avecho, InhaleRx, Neurotech, Peak, Zelira, Argent

February 02, 2026

Elixinol Achieves Operating Cash Flow Positive Quarter for the First Time

Finance

Elixinol Achieves Operating Cash Flow Positive Quarter for the First Time

February 02, 2026

Finance

InhaleRx closes A$1m capital raise and prepares to become Nexalis Therapeutics

December 01, 2025

Finance Roundup: Elixinol defends cash position; Aurora posts record quarter with Australian boost; Avecho secures funding and stays on trial schedule; Cann Group wins NAB deadline extension; InhaleRx keeps spending tight

Finance

Finance Roundup: Elixinol defends cash position; Aurora posts record quarter with Australian boost; Avecho secures funding and stays on trial schedule; Cann Group wins NAB deadline extension; InhaleRx keeps spending tight

November 04, 2025

Quick Hits: Cann Group Halts Trading; Avecho Secures $2.5m for CBD Push; IRX Boss Opts for Shares Over Pay

Finance

Quick Hits: Cann Group Halts Trading; Avecho Secures $2.5m for CBD Push; IRX Boss Opts for Shares Over Pay

October 23, 2025

Financial Roundup: Elixinol and Avecho Post Wider Losses; InhaleRx Gets Ethics Approval; Zelira Trims Deficit; Argent Steps Back From Non-Core Work

Medical

Financial Roundup: Elixinol and Avecho Post Wider Losses; InhaleRx Gets Ethics Approval; Zelira Trims Deficit; Argent Steps Back From Non-Core Work

August 29, 2025

InhaleRx posts wider half-year loss as clinical trial programs gain momentum

Finance

InhaleRx posts wider half-year loss as clinical trial programs gain momentum

August 26, 2025

InhaleRx moves closer to patient dosing in cancer pain and panic disorder programs

Medical

InhaleRx moves closer to patient dosing in cancer pain and panic disorder programs

July 23, 2025

Industry Round-Up: Elixinol Confirms CEO; Aurora Posts Record Revenue; InhaleRx Tax Rebate; ODC Launches Newsletter; Tilray Names New Australian Director

General

Industry Round-Up: Elixinol Confirms CEO; Aurora Posts Record Revenue; InhaleRx Tax Rebate; ODC Launches Newsletter; Tilray Names New Australian Director

June 20, 2025

Round-Up: Tilray enters pastille market; InhaleRx advances panic disorder study; NSW hemp plan open for comment; BS3 names new general manager

Hemp

Round-Up: Tilray enters pastille market; InhaleRx advances panic disorder study; NSW hemp plan open for comment; BS3 names new general manager

April 23, 2025

Medical

InhaleRx weighs Special Access Scheme launch while targeting big pharma partnership

March 18, 2025

InhaleRx eyes Phase 2 trial as it targets unmet need in breakthrough cancer pain treatment

Partner content

InhaleRx eyes Phase 2 trial as it targets unmet need in breakthrough cancer pain treatment

January 29, 2025

Finance

Industry Roundup: InhaleRx, Hemp Pet, Neurotech International, Cann Group

November 19, 2024

Finance

InhaleRx locks in up to $38.5m loan deal to advance cannabinoid drug trials

October 18, 2024

Finance

InhaleRx CEO Accepts Shares Instead of Cash Salary

October 02, 2024

Half-Year and Full-Year Financial Roundup: Rua Bioscience, Elixinol Wellness, Argent Biopharma, Wellnex Life, InhaleRx, Bioxyne

Finance

Half-Year and Full-Year Financial Roundup: Rua Bioscience, Elixinol Wellness, Argent Biopharma, Wellnex Life, InhaleRx, Bioxyne

September 02, 2024

ECS Botanics, Althea, InhaleRx and Neurotech International: Latest Corporate Developments

Finance

ECS Botanics, Althea, InhaleRx and Neurotech International: Latest Corporate Developments

July 10, 2024

Industry Updates: Zelira Therapeutics, Ecofibre, Cann Group, InhaleRx, Argent Biopharma, Melodiol Global Health, Wellnex Life

Finance

Industry Updates: Zelira Therapeutics, Ecofibre, Cann Group, InhaleRx, Argent Biopharma, Melodiol Global Health, Wellnex Life

July 04, 2024

Industry Roundup: Medibis, Althea, Elixinol, InhaleRx, Ecofibre, Aura Therapeutics and AusCann

Finance

Industry Roundup: Medibis, Althea, Elixinol, InhaleRx, Ecofibre, Aura Therapeutics and AusCann

April 04, 2024

Industry Updates: Folium Dispensary, Montu, Vantage Hemp Co, Cann Global, InhaleRx

Finance

Industry Updates: Folium Dispensary, Montu, Vantage Hemp Co, Cann Global, InhaleRx

March 04, 2024

Industry Roundup: Cann Global, Cann Group, InhaleRx, AusCann, Wellnex Life, Neurotech, MGC Pharma, Stenocare

Finance

Industry Roundup: Cann Global, Cann Group, InhaleRx, AusCann, Wellnex Life, Neurotech, MGC Pharma, Stenocare

December 04, 2023